Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...

Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...

Kenvue's has fired CEO Thibaut Mongon, who has also stepped down from the board, the consumer health company said on Monday, ...

Kenvue, the Johnson & Johnson spinoff that owns brands such as Tylenol and Benadryl, announced Monday that Chief Executive ...

Kenvue Inc. has announced a leadership change and the initiation of a strategic review aimed at optimizing its brand ...

Standex International CEO David Dunbar chats with NH Business Review editors on how the company continues to drive innovation in the fields of electronics, engraving, specialty technologies and ...

Kenvue plans to cut 69 jobs at its Summit HQ as part of global restructuring after splitting from Johnson & Johnson.

The report shares how Kenvue has helped advance the well-being of both people and planet in 2024, with progress noted across three pillars: Healthy People, Healthy Planet, and Healthy Practice.

On June 26, Kenvue, which is more commonly known for some of its brands like Neutrogena, Listerine, Aveeno, and Tylenol, released its second annual Healthy Lives Mission Report.